UNSPSC 51162353: Ibuprofen/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162353 Ibuprofen/pseudoephedrine (Commodity) shows minimal alignment with recent state and local procurement activity. The two solicitations tagged under this code—the Washington State Department of Corrections' request for parenteral products, services, and equipment (RFQQK13020, due October 7, 2026) and Seminole County, Florida's procurement of naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023)—involve injectable pharmaceuticals, emergency medical supplies, and specialized drug management systems rather than oral ibuprofen/pseudoephedrine combination products. The Washington DOC opportunity specifically targets parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals; the Seminole County opportunity addresses opioid-overdose reversal and drug disposal. Neither procurement represents the scope implied by the Commodity code's nominal name.

The mismatch between code and actual solicitation content suggests either miscoding in the state and local procurement management systems or a data quality issue in the source. If these opportunities represent the full recent activity under this code, the category shows no genuine market signal for ibuprofen/pseudoephedrine products at the state and local level. Business development teams should verify whether this code is actively used by target jurisdictions for its intended product class or whether procurement offices have systematically misapplied the taxonomy to pharmaceutical solicitations outside its scope.